文献速递呼吸道感染呼吸危重症与机械通气

呼吸屏气生理、影像学严重程度与COVID-19患者不良结局:一项前瞻性验证研究

Breath-holding physiology, radiological severity and adverse outcomes in COVID-19 patients: A prospective validation study.
PubMed 文献 · Respirology · 2022-08-07

该前瞻性多中心研究在110例住院COVID-19患者中验证了基于屏气动作的预测评分,发现评分升高与不良结局风险增加近五倍相关(OR=4.54,95%CI 1.17-17.83,p=0.030),且评分与胸部影像学肺受累程度呈线性相关。屏气动作或可识别未来呼吸衰竭高风险的COVID-19患者。

要点

  • 屏气预测评分升高与COVID-19不良结局风险增加近五倍相关。
  • 评分与Brixia胸片评分和CT定量肺受累均呈线性正相关。
  • 去除平均血氧饱和度下降项后,评分与不良结局的关联减弱。

核心结论

  • 屏气预测评分升高与COVID-19不良结局风险增加近五倍相关,并与胸部影像学显示的肺损伤相关。
  • 屏气动作可能有助于识别未来呼吸衰竭高风险的COVID-19患者。

研究设计与样本

  • 前瞻性验证研究,纳入110例住院COVID-19患者,来自三个招募中心。
  • 入院时进行屏气动作,基于平均血氧饱和度下降(20秒屏气)和最大屏气持续时间, plus 基线血氧饱和度、体重指数和心血管疾病计算预测评分(Messineo等)。
  • 不良结局为复合终点:双水平通气支持、ICU入住和死亡。
  • 回归分析评估评分与胸部X线(Brixia评分)和计算机断层扫描(CT;3D软件定量)的关联。
  • 与先前验证的“4C评分”进行比较。

主要发现

  • 评分升高与不良COVID-19结局相关(N=12/110),OR[95%CI]=4.54[1.17-17.83],p=0.030(阳性预测值=9/48,阴性预测值=59/62)。
  • 从预测评分中去除平均血氧饱和度下降后,结果减弱(OR=3.30[0.93-11.72])。
  • 预测评分随Brixia评分线性上升(β[95%CI]=0.13[0.02-0.23],p=0.026,N=103)。
  • 预测评分随CT定量线性上升(β=1.02[0.39-1.65],p=0.002,N=45)。
  • 平均血氧饱和度下降也与两种影像学评估相关。

关键数值与推荐

  • 预测评分升高定义为>0。
  • 不良结局复合终点包括双水平通气支持、ICU入住和死亡。
  • 4C评分高风险类别定义为≥高风险类别。

临床怎么用

  • 对于住院COVID-19患者,入院时屏气预测评分升高可提示不良结局风险增加,需加强监测。
  • 屏气评分与胸部影像学肺受累程度相关,可作为影像学评估的补充。

局限性

  • 不良结局事件数较少(N=12/110),置信区间较宽。
  • 去除平均血氧饱和度下降后关联减弱,提示该组分对预测贡献较大。
  • 4C评分的关联较弱且不显著(OR=2.44[0.62-9.56])。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: COVID-19 remains a major cause of respiratory failure, and means to identify future deterioration is needed. We recently developed a prediction score based on breath-holding manoeuvres (desaturation and maximal duration) to predict incident adverse COVID-19 outcomes. Here we prospectively validated our breath-holding prediction score in COVID-19 patients, and assessed associations with radiological scores of pulmonary involvement. METHODS: Hospitalized COVID-19 patients (N = 110, three recruitment centres) performed breath-holds at admission to provide a prediction score (Messineo et al.) based on mean desaturation (20-s breath-holds) and maximal breath-hold duration, plus baseline saturation, body mass index and cardiovascular disease. Odds ratios for incident adverse outcomes (composite of bi-level ventilatory support, ICU admission and death) were described for patients with versus without elevated scores (>0). Regression examined associations with chest x-ray (Brixia score) and computed tomography (CT; 3D-software quantification). Additional comparisons were made with the previously-validated '4C-score'. RESULTS: Elevated prediction score was associated with adverse COVID-19 outcomes (N = 12/110), OR[95%CI] = 4.54[1.17-17.83], p = 0.030 (positive predictive value = 9/48, negative predictive value = 59/62). Results were diminished with removal of mean desaturation from the prediction score (OR = 3.30[0.93-11.72]). The prediction score rose linearly with Brixia score (β[95%CI] = 0.13[0.02-0.23], p = 0.026, N = 103) and CT-based quantification (β = 1.02[0.39-1.65], p = 0.002, N = 45). Mean desaturation was also associated with both radiological assessment. Elevated 4C-scores (≥high-risk category) had a weaker association with adverse outcomes (OR = 2.44[0.62-9.56]). CONCLUSION: An elevated breath-holding prediction score is associated with almost five-fold increased adverse COVID-19 outcome risk, and with pulmonary deficits observed in chest imaging. Breath-holding may identify COVID-19 patients at risk of future respiratory failure.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Messineo L, Fanfulla F, Pedroni L, et al. Breath-holding physiology, radiological severity and adverse outcomes in COVID-19 patients: A prospective validation study. Respirology. 2022. PMID: 35933689. doi:10.1111/resp.14336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。